July 1, 2023

A Real-Time Science Report This is a reprint of a previous report. Dr. Bhatt will be back next month with a fresh update.  This article focuses...

June 1, 2023

A Real-Time Science Report I came across an interesting article about possible causes for Parkinson’s that the Parkinson’s community may like to know. Dr. Ray...

May 1, 2023

PARKINSON’S RESEARCHERS DISCOVER DISEASE BIOMARKER Parkinson’s disease is a neurodegenerative disease characterized pathologically by the formation of Lewy bodies comprised mainly of alpha-synuclein. Currently, definitive...

April 1, 2023

Parkinson’s disease is the most common neurodegenerative movement disorder characterized by bradykinesia, rigidity, postural instability, and tremor at rest. Dopamine replacement therapy is the...

March 1, 2023

A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer RISKS OF STEM CELL TRANSPLANT THERAPY FOR PARKINSON'S DISEASE On February 9, 2023, Magenta Therapeutics reported...

February 1, 2023

A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer STEM CELL THERAPY FOR PARKINSON'S DISEASE There has been a lot of talk recently on social...

January 1, 2023

A New Potential Therapeutic Target for Parkinson’s Disease Neurodegenerative Parkinson’s disease is characterized by a progressive loss of dopaminergic neurons from the nigrostriatal pathway, formation...

December 1, 2022

A Real-Time Science ReportRam S. Bhatt, PhD., Chief Science Officer EFFORTS TOWARDS A PARKINSON’S CURE The cure of any disease, including Parkinson’s, depends upon two key...

June 30, 2022

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer The Role of LRRK2 in Parkinson’s disease – Mutations in the leucine-rich repeat kinase 2...

April 28, 2022

Solving the Blood-Brain Barrier Conundrum in CNS Drug Development Last month’s editorial remarks by Jo Rosen being reprinted: in 1998 I was told by Robert...

March 31, 2022

Blood-Brain Barrier Continues to be the Main Thorn in CNS Drug Development Editorial remarks by Jo Rosen: In 1998 I was told by Robert W. Rand,...

January 31, 2022

A Unique Approach to Overcome the Deficiencies of Prior Scientific Art Patients may be wondering why there is NO CURE for Parkinson’s disease despite multi-billions...

December 29, 2021

A Real-Time Science Report Ram S. Bhatt, PhD., Chief Science Officer ICBII is named among big pharma developing technology to cross the BBB Parkinson’s Cure May Be Closer...

December 1, 2021

ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer Updates will resume next year. In the meantime, Ram S. Bhatt,...

November 1, 2021

ICBII UPDATE ON THE ROAD TO THE CURE Ram S. Bhatt, PhD., Chief Science Officer “… why hundreds of billions of dollars in global research have...